contents table Logo Lexparency.org lexp
European Medicines Agency (EMA)
Article 66

Article 66

The Management Board shall:

▼M8
(a)

adopt an opinion on the rules of procedures of the Committee for Medicinal Products for Human Use (Article 61 of this Regulation) and the Committee for Veterinary Medicinal Products (Article 139 of Regulation (EU) 2019/6);

▼B
(b)

adopt procedures for the performance of scientific services (Article 62);

(c)

appoint the Executive Director (Article 64);

(d)

adopt the annual work programme and forward it to the European Parliament, the Council, the Commission and the Member States (Article 65);

(e)

approve the annual report on the Agency's activities and forward it by 15 June at the latest to the European Parliament, the Council, the Commission, the European Economic and Social Committee, the Court of Auditors and the Member States (Article 65);

(f)

adopt the budget of the Agency (Article 67);

(g)

adopt the internal financial provisions (►M5 Article 68);

(h)

adopt provisions implementing the Staff Regulations (Article 75);

(i)

develop contacts with stakeholders and stipulate the conditions applicable (Article 78);

▼M8 ————— ▼M8
(k)

adopt rules to ensure the availability to the public of information concerning the authorisation or supervision of medicinal products for human use and of veterinary medicinal products (Article 80).

▼B